- Home
- MOLN vs CEE Comparison
MOLN vs CEE Comparison
Compare MOLN & CEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | MOLN | CEE |
|---|---|---|
| Founded | 2004 | N/A |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | | Finance Companies |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 158.9M | 128.1M |
| IPO Year | 2021 | 1994 |
Fundamental Metrics
Financial Performance| Metric | MOLN | CEE |
|---|---|---|
| Price | $5.02 | $19.55 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.38 | N/A |
| AVG Volume (30 Days) | 4.3K | ★ 23.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $285.71 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.36 | $11.20 |
| 52 Week High | $5.10 | $19.98 |
Technical Indicators
Market Signals| Indicator | MOLN | CEE |
|---|---|---|
| Relative Strength Index (RSI) | 67.88 | 61.29 |
| Support Level | $3.50 | $14.90 |
| Resistance Level | N/A | $19.98 |
| Average True Range (ATR) | 0.17 | 0.38 |
| MACD | 0.05 | -0.06 |
| Stochastic Oscillator | 97.80 | 78.24 |
Price Performance
Historical ComparisonAbout MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.